ALZHEIMER'S DISEASE TREATMENT UPDATE Scientists at UC San Francisco and the Gladstone Institutes might be on the verge of something extraordinary: reversing Alzheimer’s disease with drugs originally designed to fight cancer. In a field where progress too often feels painfully slow, their approach stands out for its creativity and its promise. Here’s how it happened. Instead of starting with a single protein—the way most Alzheimer’s drug efforts do—the team looked at the mess Alzheimer’s makes of the brain’s genetic code. Using powerful computational tools, they compared gene activity from Alzheimer’s patients’ brain cells with the effects of over 1,300 existing drugs. The idea: find medications that could undo the gene-level chaos unleashed by the disease, especially in neurons and glia—the brain’s most vulnerable cells. It wasn’t just a numbers game. The researchers also dug into millions of anonymous medical records, searching for real-world clues. They noticed something odd: pat...